COUNCIL FOR RESPONSIBLE NUTRITION

All efforts related to the inclusion of dietary supplement purchases within tax-deductible Health Savings Accounts and Flexible Spending Accounts (HSAs/FSAs), including S. 4587 and H.R. 8933, the Dietary Supplements Access Act of 2026. Issues related to IRS guidance on the classification of dietary supplements as qualified medical expenses for HSAs and FSAs (IRS Publication 502).

Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory product listing requirements for dietary supplements, including S. 3677 and H.R. 8370, the Dietary Supplement Listing Act of 2026. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision, including H.R. 10336, the Dietary Supplement Innovation Act of 2026. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to the generally recognized as safe (GRAS) process. Issues related to FDA's "Simple Reform" reorganization and its impact on dietary supplement facility inspections and specialized inspectional expertise. General issues related to the dietary supplement industry.

Issues related to tariffs and impact on the dietary supplement industry.

Issues related to recycled materials policy and environmental attribution, including H.R.7502, The Recycled Materials Attribution Act.

Monitored any issues related to the dietary supplements industry, including H.R.8962, The PERFECT Act of 2026.